However, in APC‐deficient cells, this activation can be further potentiated because CKS2, a direct transcriptional target of the β catenin/TCF4, has been shown to activate the PI3K pathway in CRC cells (Qi et al., 2016). This evidence concerns the gene TCF4 and colorectal carcinoma.